Chen‐Ni Chin - Concepedia

Author

Chen‐Ni Chin

Mersana Therapeutics (United States)ORCID

Also Known As

C.F. Chin, Chen-Ni Chin, Chen-ni Chin, Chen‐Ni Chin, Chen‐ni Chin

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Mersana Therapeutics (United States)Stockholm University University of Connecticut Yale University

About

Chen‐Ni Chin is an author at Mersana Therapeutics (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	954
2	Health Sciences	2	2	760
3	Natural Sciences	2	2	49
4	Engineering	1	1	33
5	Allergy	1	1	25

Chen‐Ni Chin

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates Shannon E. Mullican, Xiefan Lin‐Schmidt, Chen‐Ni Chin, Nature Medicine ObesityMetabolic SyndromeEnergy HomeostasisMolecular PhysiologyWeight Loss	2017	726
Rapid topology mapping of <i>Escherichia coli</i> inner-membrane proteins by prediction and PhoA/GFP fusion analysis David Drew, Dan Sjöstrand, Johan Nilsson, Proceedings of the National Academy of Sciences	2002	199
Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail Helena Andersson, Aaron M. D’Antona, Debra A. Kendall, Molecular Pharmacology	2003	123
Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of G<sub>s</sub> Vasiliki Abadji, Jean Lucas‐Lenard, Chen‐Ni Chin, Journal of Neurochemistry	1999	97
Ligand Binding and Modulation of Cyclic AMP Levels Depend on the Chemical Nature of Residue 192 of the Human Cannabinoid Receptor 1 Chen‐Ni Chin, Jean Lucas‐Lenard, Vasiliki Abadji, Journal of Neurochemistry Chemical NatureLigand BindingHuman Cannabinoid ReceptorCannabinoid PharmacologyCyclic Amp Inhibition	1998	76
The Third Transmembrane Helix of the Cannabinoid Receptor Plays a Role in the Selectivity of Aminoalkylindoles for CB2, Peripheral Cannabinoid Receptor Chen‐Ni Chin, James W. Murphy, John W. Huffman, Journal of Pharmacology and Experimental Therapeutics	1999	74
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses Naniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, Nature Communications	2024	55
Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo Heather Zhou, Chen‐Ni Chin, Margaret Wu, European Journal of Pharmacology Metabolic SyndromeInsulin SensitivityInsulin SignalingSignal TransductionMolecular Physiology	2009	34
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer Dorin Toader, Shawn P. Fessler, Scott D. Collins, Molecular Cancer Therapeutics EngineeringImmunologyImmunotherapeuticsImmunotherapyTumor Biology	2023	33
Charge pair interactions in a model transmembrane helix in the ER membrane Chen‐Ni Chin, Gunnar von Heijne Journal of Molecular Biology Membrane StructureProteinlipid InteractionCharge Pair InteractionsBiochemistryModel Transmembrane Helix	2000	28

Page 1